Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARQT | AMGN | VRTX | REGN | BMY |
| Company | Arcutis Biotherapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 8.49 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 8.84 | 276.86 | 399.31 | 897.78 | 45.38 |
| Low | 8.35 | 268.99 | 394.35 | 883.20 | 44.53 |
| Last | 8.78 | 276.38 | 396.20 | 892.48 | 44.64 |
| Change | +0.31 | +6.40 | -1.28 | +9.28 | -0.21 |
| % Change | +3.66% | +2.37% | -0.32% | +1.05% | -0.47% |
| Volume | 2,117,800 | 2,678,900 | 604,500 | 369,900 | 16,429,100 |
| 20-Day Average Volume | 2,782,955 | 2,197,460 | 935,465 | 457,565 | 13,550,811 |
| Previous Close | 8.47 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.09 | 269.65 | 400.07 | 914.70 | 49.05 |
| 20-Day Raw Stochastic | 11.49% | 67.59% | 17.38% | 19.84% | 3.33% |
| 20-Day Relative Strength | 44.74% | 51.97% | 41.62% | 37.46% | 28.65% |
| Weighted Alpha | -27.53 | +14.00 | +12.44 | +15.20 | -35.36 |
| Today's Opinion | 40% Buy | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 64% Buy | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.79% since 04/22/24 | +1.64% since 04/22/24 | -0.93% since 04/22/24 | -0.85% since 04/22/24 | -9.16% since 04/22/24 |
| Low | 8.21 on 04/25/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 9.30 on 04/23/24 | 276.86 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -11.40% since 03/28/24 | -2.79% since 03/28/24 | -5.22% since 03/28/24 | -7.27% since 03/28/24 | -17.68% since 03/28/24 |
| Low | 8.21 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 13.17 on 04/09/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +44.88% since 01/29/24 | -11.83% since 01/29/24 | -9.09% since 01/29/24 | -6.62% since 01/29/24 | -10.49% since 01/29/24 |
| Low | 5.38 on 02/07/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 13.17 on 04/09/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +276.02% since 10/27/23 | +5.66% since 10/27/23 | +11.52% since 10/27/23 | +15.13% since 10/27/23 | -12.50% since 10/27/23 |
| Low | 1.76 on 12/01/23 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 13.17 on 04/09/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 820,006 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 96,813 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 59,610,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -262,140,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 13,530,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -66,280,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 1.14 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 02/27/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |